Aspen’s shares halve after weak results

Investors are concerned that the company’s borrowings, net of cash, have increased 

Aspen’s marginal rise in revenue disappoints, but is in line with expectations

Aspen shareholders are in for an anticipated disappointment after Africa's largest pharmaceutical company's earnings grew by a mere 1% in the half year to ...

Drug maker Lilly offers half-price insulin in US

While it will continue selling its brand-name version at the existing price, Lilly will also sell a half-cost ‘authorised generic’

WATCH: Why Adrian Gore is not worried about Discovery’s dip in profit

Discovery CEO Adrian Gore talks to Business Day TV about the group’s interim results and its costly new initiatives

Adcock looks to AIDS tender to boost Wadeville plant

CEO Andy Hall says the company will not go into tenders that do not pay because, as a listed company, it cannot afford to do unprofitable business

Adcock Ingram and Aspen Pharmacare win share of government AIDS drug contract

SA’s two biggest pharmaceutical manufacturers awarded a quarter of the government’s R18.3bn drug tender

Adcock Ingram shares rise after securing state HIV drug contract

The pharmaceuticals group said its investment in local manufacturing facilities has paid off

J&J to buy robotics firm Auris Health, giving it a lung-cancer treatment tool

Auris has developed robotic surgical scopes operated with a handheld device that is steered into patients’ lungs to identify cancerous tumours

Drug firm makes cholesterol pill more affordable

Sanofi and Regeneron cut list price by 60% to give  US consumers better access and to lower out-of-pocket costs

Ascendis Health said to mull further unit sales to cut debt

The company has now earmarked its bio-science division for an additional sale

Competition Tribunal blocks Mediclinic’s bid to grow in North West

The tribunal says a proposed merger with Matlosana Medical Health Services would substantially lessen competition in the province

Ascendis anchor investor dumps another R140m worth of shares

The share has climbed from recent lows, partly on optimism that the forced sales of stock were slowing

Edward Lifesciences pays Boston Scientific $180m to end patent row

The settlement ends a long-standing dispute over medical devices

Mediclinic fights to expand in North West

SA’s biggest private hospital group presented its final argument to the Competition Tribunal

WATCH: Life Healthcare sells stake in Indian hospital group

Business Life Healthcare CEO Shrey Viranna joins Business Day TV to discuss the company’s deal with Radiant Life

Ascendis share jumps after getting offer on Remedica unit

News of the sale lifted the health company’s share price which plummeted in 2018 amid concerns about its indebtedness

Published by Tiso Blackstar and distributed with the Financial Mail on the last Thursday of every month except December and January.